CD274 and neoplasm: Tumor-associated macrophages (TAMs) are immunosuppressive cells in the TME and have been shown to contribute to T-cell dysfunction/exhaustion, resistance to anti-PD1/PDL1 therapy, and associated with worse clinical outcomes [76,77].